Intravascular Lithotripsy (IVL): a superior pathway in calcified PAD treatment
Disrupt PADIII the first level 1 evidence in severely calcified lesions.
14 décembre 2020 - 18h00 - 19h00
Disrupt PADIII the first level 1 evidence in severely calcified lesions.
Agenda
Hours indicated are CET.
|
6:00pm
|
Introduction – Meet the experts
Dr. Lorenzo Patrone |
|
| 6:03pm | An introduction to IVL technology Dr. Lorenzo Patrone |
|
| 6:07pm | PADIII: The data Prof. Gunnar Tepe |
|
| 6:20pm |
Case discussion and interactive Q&A
Live polls with discussion from the panel |
|
| 6:58pm | Conclusion Dr. Lorenzo Patrone |
|
|
The session concludes at 7pm |
||
Learning objectives
- Learn how IVL performed against PTA in the largest RCT of severely calcified lesions to date.
- Understand how Disrupt PADIII data compares to other PAD studies.
- Discover how our panellists translate the PADIII data into real world management of calcific lesions?
Target audience
- This live session is dedicated to Vascular Surgeons, Interventional Radiologists, Angiologists and Cardiologists.